The SCVC Blog

Cardiovascular care news and articles from our expert team

N-of-1: Why Your Best Health Plan Starts With You

Posted on Friday November 28, 2025 in VAT-TRAP

A new SCVC book on personalised metabolic and cardiovascular health

At Surrey Cardiovascular Clinic, one consistent pattern stands out: even when two people share the same diagnosis or the same medication, their bodies respond differently. Appetite, sleep quality, glucose responses, muscle mass, cravings and stress patterns vary widely between individuals.

A new 24 page diary — N-of-1 — is written to reflect this reality.

As a companion book in the VAT-TRAP series, N-of-1 introduces the concept of personalised metabolic improvement: you are your own study, your own experiment, your own N-of-1 trial.

What Is an N-of-1 Trial?

Whether you need to lower your blood pressure, weight or waist to improve your metabolic health and healthspan, the N-of-1 technique is a personalised experiment where you:

change one variable at a time
observe your own responses
keep what works
discard what doesn’t

This mirrors how clinicians personalise treatment daily.
Rather than following generic rules, you work with your own biology — a precision-medicine approach that research increasingly supports¹².

Why This Diary Was Developed

The book series draws on years of cardiology practice treating people with raised visceral adipose tissue (VAT, or belly fat), metabolic drift, glucose variability, weight regain and midlife loss of metabolic flexibility.

A key insight emerged:

Metabolic decline is slow, subtle and often symptomless — and metabolic recovery must be slow, steady and data-guided.

VAT accumulates invisibly over years³⁻⁷.
Sleep disruption, glucose spikes, rising fasting insulin and gradual muscle loss quietly shift the brain’s “defended” weight set point.

Short programmes and rapid weight-loss plans do not reverse these deeper systems.

N-of-1 offers a more realistic path:
a structured, reflective approach that uses small weekly changes to drive measurable long-term improvement.

Why N-of-1 Matters More Than Ever

Modern cardiometabolic science makes this clear:

VAT is a powerful driver of heart disease, metabolic syndrome, dementia and cancer³⁻⁷
Metabolic dysfunction begins long before diabetes or hypertension appear⁸
GLP-1 mimetics reduce VAT but require muscle preservation and lifestyle structure⁹
Tools like CGM, body composition scales and food-analysis apps allow precise early course-correction¹⁰⁻¹¹

N-of-1 shows how to use these tools intelligently — without overwhelm.

What You’ll Learn in the N-of-1 Book

✔ How to run an N-of-1 trial on yourself

Small weekly experiments guided by your own data, not guesswork.

✔ Why slow metabolic change works best

Because VAT biology, mitochondrial function, appetite signalling and liver metabolism adapt gradually⁴⁻⁷.

✔ The four foundations of metabolic reset

Nutrition
Movement
Muscle
Sleep

Excerpts explain simply and practically.

✔ How to interpret modern metabolic tools

Including glucose responses, body composition, measurement of VAT risk, and understanding GLP-1 effects.

✔ How to build sustainable metabolic habits

Not via intensity or restriction, but by steady repetition, reflection and insight.

Who N-of-1 is For

This book is suitable for:

anyone with waist-to-height ratio >0.5
people beginning a 12-month metabolic reset
patients using GLP-1 mimetics
individuals noticing midlife metabolic drift
anyone seeking personalised rather than generic health advice
those aiming to reduce VAT and improve long-term cardiovascular health

Why Slow Change Is More Effective

Fast approaches often:

reduce skeletal muscle
trigger rebound appetite
lower resting metabolic rate
accelerate VAT re-accumulation

Slow change allows the body to realign core systems — hypothalamic signalling, insulin sensitivity, muscle glucose uptake and circadian rhythms⁴⁻⁷.

This is the physiological basis for N-of-1:
small, steady improvements beat dramatic short-term efforts.

N-of-1 and GLP-1 Therapy

GLP-1 mimetics such as semaglutide and tirzepatide:

reduce visceral fat
improve glucose variation
lower liver fat
calm appetite

But they must be paired with nutrition, sleep and resistance training if long-term metabolic stability is the goal⁹.

N-of-1 explains how to integrate medication safely into a sustainable metabolic plan, and how to taper thoughtfully when appropriate.

A Personal Roadmap to Metabolic Health

N-of-1 is not a diet, a challenge or a fixed programme.
It is a mindset — a precision, personalised approach to long-term health.

Using modern tools, weekly reflections and structured self-experimenting, the book helps you understand:

your metabolic patterns
your sleep–glucose interactions
your biological triggers
your appetite cycles
your responsiveness to change

You cannot rush metabolic health.
But you can reclaim it — one week, one habit, one experiment at a time.

References

Guyatt G, Sackett D, Taylor DW, Ghong J, Roberts R, Pugsley S. Determining Optimal Therapy — Randomized Trials in Individual Patients. N Engl J Med [Internet]. 1986 Apr 3 [cited 2026 Feb 4];314(14):889–92. Available from: https://www.nejm.org/doi/full/10.1056/NEJM198604033141406
Kravitz RL, Duan N, Niedzinski EJ, Hay MC, Subramanian SK, Weisner TS. What Ever Happened to N-of-1 Trials? Insiders’ Perspectives and a Look to the Future. Milbank Q [Internet]. 2008 Dec [cited 2026 Feb 4];86(4):533–55. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC2690377/
Nikles CJ, Glasziou PP, Del Mar CB, Duggan CM, Mitchell G. N of 1 trials. Practical tools for medication management. Aust Fam Physician. 2000 Nov;29(11):1108–12.
Shamseer L, Sampson M, Bukutu C, Schmid CH, Nikles J, Tate R, et al. CONSORT extension for reporting N-of-1 trials (CENT) 2015: Explanation and elaboration. 2015 May 14 [cited 2026 Feb 4]; Available from: https://www.bmj.com/content/350/bmj.h1793
Lillie EO, Patay B, Diamant J, Issell B, Topol EJ, Schork NJ. The n-of-1 clinical trial: the ultimate strategy for individualizing medicine? Pers Med. 2011 Mar;8(2):161–73.

Why Cardiovascular Prevention Matters Before 30

Emerging evidence shows that lifetime exposure to LDL cholesterol and high glucose variability are some of the strongest predictors of cardiovascular risk. Just as lung cancer risk is tied to pack-years of smoking, heart disease risk correlates with cumulative LDL levels and glucose metrics such as HbA1c over time.This is why some people in their 20s with risk factors (like diabetes or a family history of heart disease) are starting statin therapy preventatively. However, many are understandably hesitant to start medication so early. Lifestyle changes remain the cornerstone of early prevention.

Patent Foramen Ovale (PFO): A Hidden Link in Stroke, TIA, Migraine and More — When to Close the Hole in the Heart

Before birth, the foramen ovale is a vital foetal opening between the right and left atria, allowing oxygen-rich placental blood to bypass the inactive lungs. After the first breath, pressure in the left atrium increases, closing the flap naturally. In around 25% of adults, the flap does not seal fully — this persistent communication is called a Patent Foramen Ovale (PFO) which is an important cause of cryptogenic stroke. All standard tests including an echocardiogram can be normal- it can be only be diagnosed using a bubble contrast study and once diagnosed, treatment with clam shell closure is high effective.

Glucose: A Matter of Life and Death

Recent scientific discoveries have aligned much like planets, leading to an inescapable conclusion among many physicians that glucose metabolism may be even more important than LDL cholesterol in the genesis of many modern diseases.